🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12123+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12123 recruiting trials

RecruitingNCT06537726

Breath Analysis for the Detection of Invasive Fungal Infections

👨‍⚕️ Jeremy Deuel, PD Dr., University of Zurich📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06565845

Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis

👨‍⚕️ Jing Feng, First Affiliated Hospital of Harbin Medical University📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06589219

Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

👨‍⚕️ Chan Beals, MD, PhD, Calibr-Skaggs Institute for Innovative Medicines📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06315738

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis

🏥 Noveome Biotherapeutics, formerly Stemnion📍 7 sites📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06371417

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

👨‍⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 67 sites📅 Started Aug 2024View details ↗
NARecruitingNCT06498817

Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)

👨‍⚕️ Christine Marie George, PhD, Johns Hopkins Bloomberg School of Public Health📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06425172

Monitoring System for Cranial Orthoses

👨‍⚕️ Tiffany Graham, MS, University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06985420

The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise

🏥 University of Central Florida📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT07316855

Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical Trial

👨‍⚕️ Taibing Fan, MD, Chinese Academy of Medical Sciences, Fuwai Hospital📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT05589896

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

🏥 Ossium Health, Inc.📍 9 sites📅 Started Aug 2024View details ↗
RecruitingNCT06680934

CABP2 Patient Registry and Natural History Study

👨‍⚕️ Tobias Moser, MD, University Medical Center Goettingen📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06395103

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 67 sites📅 Started Aug 2024View details ↗
RecruitingNCT06526689

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

👨‍⚕️ Helen McShane, PhD, University of Oxford📍 3 sites📅 Started Aug 2024View details ↗
Phase 4RecruitingNCT06294990

Klinefelter Syndrome and Testosterone Treatment in Puberty

👨‍⚕️ Lise Aksglaede, MD, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT07016724

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

👨‍⚕️ Xiangbo Wan, The First Affiliated Hospital of Zhengzhou University📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06539026

Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia

🏥 Ain Shams University📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06554626

Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL

🏥 First Affiliated Hospital of Zhejiang University📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06150742

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

🏥 Talphera, Inc📍 10 sites📅 Started Aug 2024View details ↗
NARecruitingNCT06495554

Danish Vulva Cancer Recurrence Study

👨‍⚕️ Pernille T. Jensen, Professor, Aarhus University Hospital📍 2 sites📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06546670

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

🏥 Novartis Pharmaceuticals📍 3 sites📅 Started Aug 2024View details ↗
← PreviousPage 255 of 607Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →